SCHEMBL1799780

SCHEMBL1799780

[CH2]CC(=O)OCCOC(=O)C[CH2]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.39
TSHR P16473 5/20 0.36
ALDH1A1 P00352 4/20 0.36
TP53 P04637 2/20 0.36
HIF1A Q16665 2/20 0.36
ADRA2A P08913 1/20 0.36
ADRA1A P35348 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 1/20 0.35
BLM P54132 1/20 0.35
NAAA Q02083 1/20 0.33
CYP2C19 P33261 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
THRB P10828 2/20 0.31
CYP3A4 P08684 1/20 0.31
PGR P06401 1/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
HTR1A P08908 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8979257 0.88
SCHEMBL8598315 0.87 ALDH1A1 (0.50) DGKATSHRALDH1A1ADRA2AADRA1A
SCHEMBL4851084 0.87
SCHEMBL2126469 0.85
SCHEMBL10704254 0.83
SCHEMBL5826329 0.83
SCHEMBL3280337 0.83
SCHEMBL6591538 0.83
SCHEMBL7806695 0.83
SCHEMBL51062 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615656-B2 Cycloaliphatic polyepoxy compounds and preparation thereof DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2009-11-10 US claimed
EP-2011811-B1 ACTIVE RAY CURABLE COMPOSITION, ACTIVE RAY CURABLE INKJET INK, IMAGE FORMING METHOD USING THE ACTIVE RAY CURABLE INKJET INK, AND INKJET RECORDING APPARATUS KONICA MINOLTA MED & GRAPHIC (JP) 2015-03-18 EP disclosed
US-8642675-B2 Actinic ray curable composition, actinic ray curable ink-jet ink, image forming method and ink-jet recording apparatus utilizing said actinic ray curable ink-jet ink KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2014-02-04 US disclosed
EP-2149457-B1 Inkjet recording method, inkjet recording system, and printed material FUJIFILM CORP (JP) 2013-04-10 EP disclosed
EP-2347904-B1 Ink set and ink-jet recording method utilizing uv-curable ink KONICA MINOLTA MED & GRAPHIC (JP) 2013-04-03 EP disclosed
EP-1829939-B1 ACTIVE RAY-CURABLE INKJET INK AND IMAGE-FORMING METHOD USING SAME KONICA MINOLTA MED & GRAPHIC (JP) 2012-10-17 EP disclosed
EP-2347904-A2 Inkset, ink-jet recording method and ink-jet recording device utilizing uv-curable ink Konica Minolta Medical & Graphic, Inc. (JP) 2011-07-27 EP disclosed
US-7950795-B2 Image forming method and ink-jet recording device utilizing photo-curable ink, and inkset, ink-jet recording method and ink-jet recording device utilizing photo-curable ink KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-05-31 US disclosed
US-7749573-B2 Actinic radiation curable ink-jet ink and image forming method using the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2010-07-06 US disclosed
US-20100144917-A1 ACTINIC ENERGY RADIATION HARDENABLE COMPOSITION AND EPOXY COMPOUND KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2010-06-10 US disclosed
US-20050190252-A1 Active ray curable ink, image forming method and ink-jet recording apparatus KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2005-09-01 US disclosed
US-20050165123-A1 Actinic ray curable composition, image forming method using the same and ink-jet recording apparatus using the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2005-07-28 US disclosed
US-20050148687-A1 Cationic polymerizable composition, actinic ray curable ink-jet ink and stabilization method of the cationic polymerizable composition KONICA MINOLTA MEDICAL & GRAPHIC, INC 2005-07-07 US disclosed
US-20050119362-A1 Actinic ray curable composition, actinic ray crable ink, image formation method employing it, and ink-jet recording apparatus KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2005-06-02 US disclosed
US-20040252171-A1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2004-12-16 US disclosed
EP-1486526-A1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method Konica Minolta Medical & Graphic, Inc. (JP) 2004-12-15 EP disclosed
US-20040244641-A1 Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2004-12-09 US disclosed
EP-1484370-A1 Photocurable ink, and image recording apparatus and image recording method employing the photocurable ink Konica Minolta Medical & Graphic, Inc. (JP) 2004-12-08 EP disclosed
US-20040241578-A1 Photocurable ink, and image recording apparatus and image recording method employing the photocurable ink KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2004-12-02 US disclosed
US-20040167315-A1 Active energy ray curable composition KONICA MINOLTA HOLDINGS, INC. (JP) 2004-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040244641-A1 Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound JAK1, INO80, ROR1 DGKA 4102/4885TSHR 3739/4885ALDH1A1 3331/4885
US-20100144917-A1 ACTINIC ENERGY RADIATION HARDENABLE COMPOSITION AND EPOXY COMPOUND EEF1A1, RAD51, EPN1 DGKA 2706/4885TSHR 4380/4885ALDH1A1 1520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.